Reduction The Hormone Estrogen Leads To Mental Decline.
The younger a missus is when she undergoes surgical menopause, the greater her chances of developing tribute problems at an earlier age, brand-new research suggests. Surgical menopause describes the end of ovarian occasion due to gynecological surgery before the age of natural menopause. It involves the removal of one or both ovaries (an oophorectomy), often in alliance with a hysterectomy, the removal of a woman's uterus is jes extender safe. "For women with surgically induced menopause, first age at menopause was associated with a faster decline in memory," said sanctum author Dr Riley Bove, an instructor in neurology at Harvard Medical School and an companion neurologist at Brigham and Women's Hospital in Boston.
However "These are very preliminary data". Bove said other inspection suggests a link between a decrease in the hormone estrogen during menopause and mental decline, and the point of this study was to better understand the relationship between reproductive-health factors and memory changes tablets. The study results will be presented in March at the American Academy of Neurology' annual meeting, in San Diego.
For the study, the researchers analyzed medical records of more than 1800 women venerable 53 to 100 who were taking faction in one of two studies conducted by Rush University Medical Center in Chicago: the Religious Orders Study and the Memory and Aging Project. The researchers assessed reproductive variables, such as when women had their beforehand period, the swarm of years menstrual cycles lasted, and use of hormone replacement therapies. Measurements from several types of outlook and celebration tests were analyzed, too.
The scientists also assessed the results of capacity biopsies after death, some of which showed the presence of Alzheimer's plaques. "We had approximately 580 brains elbow for analysis - this speaks to the very unique and rich nature of the data". Thirty-three percent of the den participants had undergone surgical menopause.
Reasons for these surgeries may include fibroids (noncancerous uterine tumors), endometriosis (growth of uterine conglomeration outside the womb), cancer of the uterus and ovaries, and aberrant vaginal bleeding. When the ovaries are gone, ovarian production of estrogen stops, said Bove. However, this swot did not include reasons why the women underwent surgical menopause.
Showing posts with label estrogen. Show all posts
Showing posts with label estrogen. Show all posts
Thursday, 2 May 2019
Wednesday, 7 June 2017
Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy
Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy.
In a decree that seems to chip the prevailing wisdom that any form of hormone replacement treatment raises the risk of breast cancer, a new look at some old data suggests that estrogen-only hormone remedy might protect a small subset of postmenopausal women against the disease. "Exogenous estrogen such as hormone remedial programme is actually protective" in women who have a low risk for developing core tumors, said study author Dr Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver howporstarsgrowit.com. With his colleagues, Ragaz took another glance at material from the Women's Health Initiative (WHI) study, a public trial that has focused on ways to prevent breast and colorectal cancer, as well as nub disease and fracture risk, in postmenopausal women.
The team planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by shell experts, atypical studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary tryvimax. Launched in 1991, the WHI includes more than 161000 US women between the ages of 50 and 79.
Two groups were vicinage of the side - women who had had hysterectomies and took estrogen abandoned as hormone replacement therapy and a group that took estrogen plus progestin hormone replacement therapy. The bloc therapy trial was halted in 2002 after it became clear those women were at increased gamble for heart disease and breast cancer.
In the new look at the estrogen-only group "we looked at women who did not have high-risk features". They found that women with no old history of benign teat disease had a 43 percent reduction breast cancer risk on estrogen; women with no issue history with a first-degree relative with breast cancer had a 32 percent risk reduction and women without former hormone use had a 32 percent reduced risk.
In a decree that seems to chip the prevailing wisdom that any form of hormone replacement treatment raises the risk of breast cancer, a new look at some old data suggests that estrogen-only hormone remedy might protect a small subset of postmenopausal women against the disease. "Exogenous estrogen such as hormone remedial programme is actually protective" in women who have a low risk for developing core tumors, said study author Dr Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver howporstarsgrowit.com. With his colleagues, Ragaz took another glance at material from the Women's Health Initiative (WHI) study, a public trial that has focused on ways to prevent breast and colorectal cancer, as well as nub disease and fracture risk, in postmenopausal women.
The team planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by shell experts, atypical studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary tryvimax. Launched in 1991, the WHI includes more than 161000 US women between the ages of 50 and 79.
Two groups were vicinage of the side - women who had had hysterectomies and took estrogen abandoned as hormone replacement therapy and a group that took estrogen plus progestin hormone replacement therapy. The bloc therapy trial was halted in 2002 after it became clear those women were at increased gamble for heart disease and breast cancer.
In the new look at the estrogen-only group "we looked at women who did not have high-risk features". They found that women with no old history of benign teat disease had a 43 percent reduction breast cancer risk on estrogen; women with no issue history with a first-degree relative with breast cancer had a 32 percent risk reduction and women without former hormone use had a 32 percent reduced risk.
Friday, 11 December 2015
Menopause Affects Women Differently
Menopause Affects Women Differently.
Women bothered by prurient flashes or other things of menopause have a number of treatment options - hormonal or not, according to updated guidelines from the American College of Obstetricians and Gynecologists. It's estimated that anywhere from 50 percent to 82 percent of women succeeding through menopause have ardent flashes - sudden feelings of extreme excitement in the upper body - and night sweats provillus shop. For many, the symptoms are frequent and severe enough to cause catch forty winks problems and disrupt their daily lives.
And the duration of the misery can last from a couple years to more than a decade, says the college, the nation's unrivalled group of ob/gyns. "Menopausal symptoms are common, and can be very bothersome to women," said Dr Clarisa Gracia, who helped pen the new guidelines. "Women should cognizant of that effective treatments are available to address these symptoms" sildenafilrx.net. The guidelines, published in the January consummation of Obstetrics andamp; Gynecology, reinforce some longstanding advice: Hormone therapy, with estrogen unaccompanied or estrogen plus progestin, is the most effective way to cool hot flashes.
But they also amateur out the growing evidence that some antidepressants can help an associate professor of obstetrics and gynecology at the University of Pennsylvania in Philadelphia. In studies, despondent doses of antidepressants such as venlafaxine (Effexor) and fluoxetine (Prozac) have helped lift hot flashes in some women. And two other drugs - the anti-seizure tranquillizer gabapentin and the blood pressure medication clonidine - can be effective, according to the guidelines.
So far, though, only one non-hormonal medicine is actually approved by the US Food and Drug Administration for treating sensitive flashes: a low-dose version of the antidepressant paroxetine (Paxil). And experts said that while there is witness some hormone alternatives ease hot flashes, none works as well as estrogen and estrogen-progestin. "Unfortunately, many providers are faint-hearted to prescribe hormones.
And a lot of the time, women are fearful," said Dr Patricia Sulak, an ob/gyn at Scott andamp; White Hospital in Temple, Texas, who was not intricate in penmanship the new guidelines. Years ago, doctors routinely prescribed hormone replacement remedy after menopause to lower women's risk of heart disease, among other things. But in 2002, a solid US trial called the Women's Health Initiative found that women given estrogen-progestin pills in actuality had slightly increased risks of blood clots, heart attack and breast cancer. "Use of hormones plummeted" after that.
Women bothered by prurient flashes or other things of menopause have a number of treatment options - hormonal or not, according to updated guidelines from the American College of Obstetricians and Gynecologists. It's estimated that anywhere from 50 percent to 82 percent of women succeeding through menopause have ardent flashes - sudden feelings of extreme excitement in the upper body - and night sweats provillus shop. For many, the symptoms are frequent and severe enough to cause catch forty winks problems and disrupt their daily lives.
And the duration of the misery can last from a couple years to more than a decade, says the college, the nation's unrivalled group of ob/gyns. "Menopausal symptoms are common, and can be very bothersome to women," said Dr Clarisa Gracia, who helped pen the new guidelines. "Women should cognizant of that effective treatments are available to address these symptoms" sildenafilrx.net. The guidelines, published in the January consummation of Obstetrics andamp; Gynecology, reinforce some longstanding advice: Hormone therapy, with estrogen unaccompanied or estrogen plus progestin, is the most effective way to cool hot flashes.
But they also amateur out the growing evidence that some antidepressants can help an associate professor of obstetrics and gynecology at the University of Pennsylvania in Philadelphia. In studies, despondent doses of antidepressants such as venlafaxine (Effexor) and fluoxetine (Prozac) have helped lift hot flashes in some women. And two other drugs - the anti-seizure tranquillizer gabapentin and the blood pressure medication clonidine - can be effective, according to the guidelines.
So far, though, only one non-hormonal medicine is actually approved by the US Food and Drug Administration for treating sensitive flashes: a low-dose version of the antidepressant paroxetine (Paxil). And experts said that while there is witness some hormone alternatives ease hot flashes, none works as well as estrogen and estrogen-progestin. "Unfortunately, many providers are faint-hearted to prescribe hormones.
And a lot of the time, women are fearful," said Dr Patricia Sulak, an ob/gyn at Scott andamp; White Hospital in Temple, Texas, who was not intricate in penmanship the new guidelines. Years ago, doctors routinely prescribed hormone replacement remedy after menopause to lower women's risk of heart disease, among other things. But in 2002, a solid US trial called the Women's Health Initiative found that women given estrogen-progestin pills in actuality had slightly increased risks of blood clots, heart attack and breast cancer. "Use of hormones plummeted" after that.
Subscribe to:
Posts (Atom)